Comparative Pharmacology
Head-to-head clinical analysis: PRISMASOL B22GK 2 0 IN PLASTIC CONTAINER versus PRISMASOL BK 0 0 1 2 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRISMASOL B22GK 2 0 IN PLASTIC CONTAINER versus PRISMASOL BK 0 0 1 2 IN PLASTIC CONTAINER.
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER vs PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prismasol B22GK 2/0 is a solution used in continuous renal replacement therapy (CRRT) to correct electrolyte imbalances and remove waste products. It provides bicarbonate as a buffer via metabolism of lactate or acetate, and contains electrolytes to maintain homeostasis.
Prismasol BK 0/0/1.2 is a sterile, nonpyrogenic, bicarbonate-buffered solution used for continuous renal replacement therapy (CRRT). It provides electrolyte composition to maintain acid-base balance and electrolyte homeostasis during hemofiltration or hemodialysis. Its mechanism involves correction of metabolic acidosis via bicarbonate buffer, and removal of uremic toxins through convective and/or diffusive clearance.
Continuous renal replacement therapy (CRRT): prescription as per institutional protocol, typically 2000-2500 mL/h effluent rate (dialysate + replacement fluid) for adults. Peritoneal dialysis: 2-3 L exchanges, 4-5 times daily or cycler. Intravenous infusion only via CRRT or as dialysate/replacement fluid.
Continuous renal replacement therapy (CRRT): 1.2 mmol/L potassium dialysate/ replacement fluid, infused at a rate of 2000-3000 mL/hour, adjusted to achieve desired electrolyte balance and fluid removal.
None Documented
None Documented
Not applicable; PRISMASOL B22GK 2/0 is a dialysate solution for CRRT. Components (glucose, electrolytes, lactate/bicarbonate) are continuously removed and replaced. For buffer conversion: lactate half-life ~5 minutes (hepatic metabolism to bicarbonate).
Not applicable as a drug; the half-life of bicarbonate in CRRT depends on the dialysis dose and patient's metabolic rate. Typical half-life of infused bicarbonate is minutes due to rapid equilibration. The electrolytes are continuously removed during therapy.
Renal (100%); eliminated unchanged by ultrafiltration and diffusion during continuous renal replacement therapy (CRRT). Biliary/fecal: negligible.
PRISMASOL BK 0/0/1.2 is a bicarbonate-based substitution fluid used in continuous renal replacement therapy (CRRT). It is not absorbed systemically; its components are eliminated according to their individual pharmacokinetics during CRRT. Bicarbonate is primarily eliminated via the dialysate/effluent (renal replacement route). Calcium and magnesium are also removed via CRRT. Less than 1% is excreted in feces or bile.
Category C
Category C
Dialysis Solution
Dialysis Solution